Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Phase I Single-center, Single-blind, Randomized Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01

NCT06710561 is registered in ClinicalTrials.gov with Beijing SonoPhotoNano Medical Technology Co., Ltd. as lead sponsor.

NCT NCT06710561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Phase I Single-center, Single-blind, Randomized Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01
Lead sponsor
Beijing SonoPhotoNano Medical Technology Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 17, 2024
Completion date
April 10, 2026
Enrollment
32 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma